Home › Funds › Paradigm Biocapital Advisors LP › EYPT

Paradigm Biocapital Advisors LP position in EYPT

EYEPOINT INC · Industrials

Paradigm Biocapital Advisors LP reported holding 2,890,397 shares of EYPT (EYEPOINT INC) in its Q2 2026 13F filing — a position valued at US$41.3M, representing 0.77% of its reported portfolio and ranking #21 among its reported holdings. Paradigm Biocapital Advisors LP has disclosed EYPT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)2.89M sh
Reported value held$41.33M
Portfolio Weight0.77%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Paradigm Biocapital Advisors LP's EYPT position evolved

Paradigm Biocapital Advisors LP first disclosed a stake in EYPT in Q3 2025 at 2,005,365 shares (US$28.6M). The position peaked in Q4 2025 at 3,691,475 shares, worth US$67.4M. Across 4 filings, Paradigm Biocapital Advisors LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,890,397 shares valued at US$41.3M — a reduction of -252,040 shares quarter over quarter.. Notable position changes include a 84% increase in Q4 2025 (shares fell 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 2.01M $28.56M New
Q4 2025 3.69M $67.44M Add
Q1 2026 3.14M $40.51M Reduce
Q2 2026 2.89M $41.33M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EYPT and 13F data

EYPT (EYEPOINT INC) is a Industrials company. 42 other funds we track also report a position in EYPT — the largest reported positions include MONTANOVA CAPITAL, LLC (US$118.6M), Cormorant Asset Management, LP (US$100.1M), Commodore Capital LP (US$65.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EYPT

All EYPT fund holders →

FAQ

How long has Paradigm Biocapital Advisors LP held EYPT?

Paradigm Biocapital Advisors LP has disclosed EYPT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Paradigm Biocapital Advisors LP's current position in EYPT?

As of Q2 2026, Paradigm Biocapital Advisors LP holds 2.89M shares of EYPT (EYEPOINT INC), valued at $41.33M, representing 0.77% of its reported portfolio and ranking #21.

Has Paradigm Biocapital Advisors LP been buying or selling EYPT?

In the latest 13F filing (Q2 2026), Paradigm Biocapital Advisors LP reduced its position in EYPT. The position peaked in Q4 2025 at 3.69M shares.

Which other funds hold EYPT?

Other major institutional holders of EYPT include MONTANOVA CAPITAL, LLC, Cormorant Asset Management, LP, Commodore Capital LP, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.